Related Experiment Videos
Null effects of vitamin A analogs on the dimethylnitrosamine kidney tumor model
Abstract:
The effect of retinoids on the induction of both epithelial and mesenchymal tumors of the rat kidney by a single dose of 40 mg/kg dimethylnitrosamine was tested using 13-cis-retinoic acid and the trimethylmethoxy phenyl analog of retinoic acid ethylamide. 13-cis-retinoic acid was administered for 3 weeks, 10 weeks, or 26 weeks, post-carcinogen treatment, in order to coincide with known morphological phases occurring within the kidney which culminated in the development of macroscopic tumors. The ethylamide analog and placebo beadlets were administered for the 26 week period only. None of the retinoid schedules significantly influenced the survival of the animals, nor the incidences of renal mesenchymal tumors or renal cell adenomas/adenocarcinomas. Tumor latency, histological grade or frequency of metastatic invasion were also unaltered by the treatments. Possible reasons for the observed lack of effect are discussed, including speculation regarding the potency of this single-dose model of chemical carcinogenesis.
Insights
This study investigated retinoids' effects on rat kidney tumors induced by dimethylnitrosamine. Neither 13-cis-retinoic acid nor its analog altered tumor incidence, survival, or metastasis, suggesting limited efficacy in this model.
Area of Science:
- Oncology
- Pharmacology
- Toxicology
Background:
- Retinoids are vitamin A derivatives with known roles in cell differentiation and proliferation.
- Chemical carcinogenesis models are crucial for understanding tumor development and testing potential therapeutic agents.
- Kidney tumors can arise from both epithelial and mesenchymal cell lineages.
Purpose of the Study:
- To evaluate the chemopreventive potential of retinoids against dimethylnitrosamine-induced rat kidney tumors.
- To assess the impact of retinoid administration timing on tumor development.
- To investigate the effects of retinoids on tumor incidence, latency, grade, and metastasis.
Main Methods:
- Rats were administered a single dose of dimethylnitrosamine to induce kidney tumors.
- Test groups received 13-cis-retinoic acid or a retinoic acid ethylamide analog at various time points post-carcinogen exposure.
- Control groups received placebo beadlets.
Main Results:
- No significant differences were observed in animal survival rates across treatment groups.
- Retinoid treatments did not significantly alter the incidence of renal mesenchymal tumors or renal cell adenomas/adenocarcinomas.
- Tumor latency, histological grade, and metastatic invasion frequency remained unaffected by retinoid administration.
Conclusions:
- The tested retinoids did not demonstrate significant chemopreventive effects in this single-dose dimethylnitrosamine-induced rat kidney tumor model.
- The lack of efficacy may be attributed to the specific model used or the retinoids' potency.
- Further research is needed to explore retinoid efficacy in different carcinogenesis models or with varied therapeutic strategies.